These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7647019)

  • 21. Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy.
    Bokarewa MI; Bremme K; Blombäck M
    Br J Haematol; 1996 Feb; 92(2):473-8. PubMed ID: 8603019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to activated protein C decreases throughout pregnancy.
    Benedetto C; Marozio L; Tavella AM; Maulà V; Carmignani D; Curti A
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1028-32. PubMed ID: 12421170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A chromogenic assay for activated protein C resistance.
    Váradi K; Moritz B; Lang H; Bauer K; Preston E; Peake I; Rivard GE; Keil B; Schwarz HP
    Br J Haematol; 1995 Aug; 90(4):884-91. PubMed ID: 7669667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
    Svensson PJ; Zöller B; Dahlbäck B
    Thromb Haemost; 1997 Feb; 77(2):332-5. PubMed ID: 9157592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombotic risk factors and oral contraception.
    Bokarewa MI; Falk G; Sten-Linder M; Egberg N; Blombäck M; Bremme K
    J Lab Clin Med; 1995 Sep; 126(3):294-8. PubMed ID: 7665978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical application of a new specific functional assay to detect the factor V(Leiden) mutation associated with activated protein C resistance.
    van Oerle R; van Pampus L; Tans G; Rosing J; Hamulyák K
    Am J Clin Pathol; 1997 May; 107(5):521-6. PubMed ID: 9128263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APC resistance: biological basis and acquired influences.
    Castoldi E; Rosing J
    J Thromb Haemost; 2010 Mar; 8(3):445-53. PubMed ID: 20002539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene.
    Aparicio C; Dahlbäck B
    Biochem J; 1996 Jan; 313 ( Pt 2)(Pt 2):467-72. PubMed ID: 8573079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acquired resistance to activated protein C in pregnancy].
    Schneider DM; von Tempelhoff GF; Hoppenstaedt D; Fareed J; Heilmann L
    Z Geburtshilfe Neonatol; 1998; 202(3):107-10. PubMed ID: 9715525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM; Koeleman BP; Koster T; Rosendaal FR; Dirven RJ; de Ronde H; van der Velden PA; Reitsma PH
    Nature; 1994 May; 369(6475):64-7. PubMed ID: 8164741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.
    Dahlbäck B
    Haemostasis; 1994; 24(2):139-51. PubMed ID: 7959362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal evaluation of activated protein C resistance among normal pregnancies of Hispanic women.
    Fassett MJ; Bohn YC; Kuo J; Wing DA
    Am J Obstet Gynecol; 2000 Jun; 182(6):1433-6. PubMed ID: 10871461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thrombosis after caesarean section in a young woman with homozygous APC resistance and type I protein S deficiency.
    Biasiutti FD; Stucki B; Solenthaler M; Tobler A; Furlan M; Lämmle B
    Eur J Haematol; 1997 Feb; 58(2):127-9. PubMed ID: 9111596
    [No Abstract]   [Full Text] [Related]  

  • 35. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy.
    Clark P; Brennand J; Conkie JA; McCall F; Greer IA; Walker ID
    Thromb Haemost; 1998 Jun; 79(6):1166-70. PubMed ID: 9657443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia.
    Tchaikovski SN; Thomassen MC; Costa SD; Peeters LL; Rosing J
    Thromb Haemost; 2011 Nov; 106(5):914-21. PubMed ID: 21979881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated protein C resistance can be associated with recurrent fetal loss.
    Brenner B; Mandel H; Lanir N; Younis J; Rothbart H; Ohel G; Blumenfeld Z
    Br J Haematol; 1997 Jun; 97(3):551-4. PubMed ID: 9207398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
    Spannagl M; Schramm W
    Dtsch Med Wochenschr; 1998 Feb; 123(6):137-9. PubMed ID: 9505951
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF; Lensen RP; Bertina RM
    Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
    Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I
    Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.